Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| Quest Diagnostics (NYSE: DGX) | Delayed: 238.93 +1.81 (0.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $237.12 | 52 Week High | $86.85 | |||
| Open | $235.34 | 52 Week Low | $59.66 | |||
| Day High | $240.56 | P/E | 45.00 | |||
| Day Low | $223.50 | EPS | $5.31 | |||
| Volume | 1,205,052 | |||||
